Liothyronine
Showing 1 - 25 of 44
Hypothyroidism Trial in Modena (Liothyronine, Levothyroxin, Placebos)
Completed
- Hypothyroidism
- Liothyronine
- +2 more
-
Modena, ItalyAziendaUSLModena
Jul 27, 2022
Thyroid Goiter, Hypothyroidism, Thyroid Cancer Trial in Richmond (Levothyroxine, Liothyronine, Placebo)
Recruiting
- Thyroid Goiter
- +2 more
- Levothyroxine
- +2 more
-
Richmond, VirginiaVirginia Commonwealth University
Apr 25, 2022
Healthy Trial in Richmond (Liothyronine, Levothyroxine, Placebos)
Completed
- Healthy
- Liothyronine
- +2 more
-
Richmond, VirginiaVirginia Commonwealth University
Mar 2, 2021
Metastatic Breast Cancer, Thyroid Dysfunction Trial in Canton (Triiodothyronine (T3))
Terminated
- Metastatic Breast Cancer
- Thyroid Dysfunction
- Triiodothyronine (T3)
-
Canton, OhioAultman Medical Group Hematology and Oncology
May 11, 2022
Heart Failure With Preserved Ejection Fraction, Low Triiodothyronine Syndrome Trial in Philadelphia (liothyronine or )
Recruiting
- Heart Failure With Preserved Ejection Fraction
- Low Triiodothyronine Syndrome
- liothyronine or placebo
-
Philadelphia, PennsylvaniaPenn Medicine
Dec 21, 2021
Autoimmune Hypothyroidism Trial in Netherlands (LT3 (liothyronine), Placebo)
Recruiting
- Autoimmune Hypothyroidism
- LT3 (liothyronine)
- Placebo
-
Amsterdam, Netherlands
- +14 more
Jan 4, 2023
Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Atlanta (Liothyronine, Lomustine, Methimazole)
Recruiting
- Recurrent Glioblastoma
- Recurrent Gliosarcoma
- Liothyronine
- +2 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Feb 23, 2022
Subclinical Hypothyroidism Trial in Philadelphia (Levothyroxine, Liothyronine, Thyrotropin-Releasing Hormone)
Completed
- Subclinical Hypothyroidism
- Levothyroxine
- +2 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Feb 16, 2021
Hypothyroidism, Biomarkers, Endocrine System Diseases Trial in Oslo (Levothyroxin, Liothyronine)
Completed
- Hypothyroidism
- +2 more
- Levothyroxin
- Liothyronine
-
Oslo, NorwayOslo University Hospital
Mar 12, 2021
DIO2 and MCT10 Genes and Effect of Triiodothyronine Treatment
Recruiting
- Hypothyroidism
-
Herlev, DenmarkHerlev Hospital
Apr 6, 2021
ARDS, Human, Lung, Wet, Thyroid Trial in United States (Liothyronine Sodium (T3) (modified formulation))
Recruiting
- ARDS, Human
- +4 more
- Liothyronine Sodium (T3) (modified formulation)
-
Duluth, Minnesota
- +4 more
Sep 24, 2021
Synthetic Thyroid Hormone for Thyroid Cancer Treatment
Completed
- Malignant Struma Ovarii
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 25, 2020
Heart Failure, Low T3 Syndrome Trial in Herlev (Liothyronine)
Completed
- Heart Failure
- Low T3 Syndrome
- Liothyronine
-
Herlev, DenmarkHerlev Hospital, Dept. of Endocrinology
Jul 12, 2019
Insulin Resistance, Diabetes, Abnormal Glucose Metabolism Trial run by the NIDDK (Liothyronine)
Completed
- Insulin Resistance
- +2 more
- Liothyronine
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 12, 2019
Prostate Cancer Trial in Rochester (biological, drug, genetic, other, radiation)
Terminated
- Prostate Cancer
- Ad5-CMV-NIS
- +4 more
-
Rochester, MinnesotaMayo Clinic
Nov 20, 2019
Multiple Sclerosis Trial in Portland (Liothyronine sodium, Placebo)
Completed
- Multiple Sclerosis
- Liothyronine sodium
- Placebo
-
Portland, OregonOregon Health and Science University
May 24, 2018
Brain and CNS Tumors, Intraocular Melanoma, Lung Cancer Trial in New York (genetic, other, radiation)
Active, not recruiting
- Brain and Central Nervous System Tumors
- +9 more
- DNA analysis
- +4 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Oct 28, 2021
Mild Cognitive Impairment, Dementia, Mild Trial in United States (dietary supplement, combination product, behavioral)
Not yet recruiting
- Mild Cognitive Impairment
- Dementia, Mild
- Precision Medicine Approach
- +3 more
-
Folsom, California
- +5 more
May 30, 2023
Head Neck Cancer Trial in United Kingdom (recombinant thyroid-stimulating hormone, Radiodine ablation without rhTSH)
Active, not recruiting
- Head and Neck Cancer
- recombinant thyroid-stimulating hormone
- Radiodine ablation without rhTSH
-
Brighton, England, United Kingdom
- +24 more
Oct 13, 2021
Serum rT3 Concentrations, T3/T4 Ratio, and Symptoms/Quality of
Recruiting
- Hypothyroidism
- Quality of life assessment, biochemical measures
-
Budapest, HungarySemmelweis University - Departement Medicine and Oncology
Sep 21, 2021
Pulmonary Infection, Covid-19 Trial in Haidari/Athens (T3 solution for injection, Placebo)
Terminated
- Pulmonary Infection
- Covid-19
- T3 solution for injection
- Placebo
-
Haidari/Athens, GreeceAttikon University General Hospital
Sep 16, 2021
Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis, Primary Progressive
Completed
- Multiple Sclerosis, Relapsing-Remitting
- +2 more
- liothyronine
-
Baltimore, MarylandThe Johns Hopkins Hospital
Feb 8, 2018
Thyroid Tumor Trial run by the NCI (Valproic Acid, Liothyronine Sodium)
Completed
- Thyroid Neoplasm
- Valproic Acid
- Liothyronine Sodium
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 16, 2018
Congenital Heart Defects Trial in Los Angeles, Palo Alto, Seattle (Triostat, Placebo)
Unknown status
- Congenital Heart Defects
- Triostat
- Placebo
-
Los Angeles, California
- +2 more
Jul 18, 2018
Thyroid and Fat Tissue Metabolism
Completed
- Healthy Volunteers
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 5, 2017